RecallDepth
Class II Terminated

Prolia (denosumab) Injection, 60 mg/mL, 1 x 60 mg Single Use Prefilled Syringe per carton, Rx only, Manufactured by: Amgen Manufacturing Ltd., a subsidiary of Amgen Inc., Thousand Oaks, CA 91320-1799,NDC 55513-710-01, UPC 3 55513 71001 5.

Company
Amgen, Inc.
Recall Initiated
September 17, 2013
Posted
November 13, 2013
Recall Number
D-66318-001
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
4,163 prefilled syringes
Firm Location
Thousand Oaks, CA, United States

Reason for Recall

Presence of Particulate Matter: Visible cellulose fibers were observed in a small number of prefilled syringes during a routine quality examination.

Distribution

Nationwide and Puerto Rico, Canada, Mexico, and clinical distribution in Europe.

Lot / Code Info

Lot #: 1037592, Exp 07/15

More recalls by Amgen, Inc.

View all recalls by this company →

Other recent Class II Drug recalls